Neurality builds AI software for auditory brainstem response (ABR) audiometry, a diagnostic test used to detect hearing loss, particularly in infants and patients who cannot complete a standard hearing test. The company was founded in 2019 and is based in Lodz, Poland.
Traditional ABR testing requires a trained specialist to manually classify waveform patterns, a process that can leave patients waiting weeks for results. Neurality's software automates that classification, distinguishing normal from pathological patterns with reported accuracy up to 97% and returning results immediately rather than after a manual review queue, while working offline and integrating with existing ABR measurement equipment.
Neurality targets audiologists, pediatric hearing clinics, telehealth providers, and hearing-aid manufacturers rather than consumers testing their own hearing at home. The company does not publish pricing; interested clinics and organizations request a demo and receive a custom quote, and public company data lists Neurality as an unfunded startup as of this writing.
